Cargando…
Endocan silencing induces programmed cell death in hepatocarcinoma
Hepatocarcinoma is a type of high-grade malignant carcinoma identified worldwide. Its rapid development and late diagnosis prevents effective tumor resection in the majority of patients, and therefore recent studies have targeted metabolic signaling pathways and the tumor microenvironment for potent...
Autores principales: | Yang, Jinghui, Sheng, Shihou, Yang, Qiwei, Li, Li, Qin, Shaoyou, Yu, Shan, Zhang, Xuewen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661370/ https://www.ncbi.nlm.nih.gov/pubmed/29113167 http://dx.doi.org/10.3892/ol.2017.6857 |
Ejemplares similares
-
Effects of STAT3 Gene Silencing and Rapamycin on Apoptosis in Hepatocarcinoma Cells
por: Zhang, Yi, et al.
Publicado: (2012) -
Endocan and Erectile Dysfunction
por: Balta, Sevket, et al.
Publicado: (2019) -
Effects of TLR4 gene silencing on the proliferation and apotosis of hepatocarcinoma HEPG2 cells
por: LIU, YATING, et al.
Publicado: (2016) -
Endocan: A Key Player of Cardiovascular Disease
por: Chen, Jinzhi, et al.
Publicado: (2022) -
The Role of Endocan in Cardiometabolic Disorders
por: Klisic, Aleksandra, et al.
Publicado: (2023)